Health Care [ 7/12 ] | Biotechnology [ 56/74 ]
NASDAQ | Common Stock
Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products.
Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, as well as for the treatment of advanced solid tumors.
The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021.
Indaptus Therapeutics, Inc. is headquartered in New York, New York.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Dec 31, 25 | -9.19 Decreased by -2.38 K% | -4.36 Decreased by -110.78% |
| Nov 12, 25 | -2.98 Decreased by -831.25% | -0.20 Decreased by -1.39 K% |
| Aug 13, 25 | -9.09 Decreased by -1.83 K% | -0.19 Decreased by -4.68 K% |
| May 14, 25 | -9.00 Decreased by -1.90 K% | -0.18 Decreased by -4.90 K% |
| Mar 13, 25 | -0.37 Increased by +22.92% | -0.47 Increased by +21.28% |
| Nov 12, 24 | -0.32 Increased by +31.91% | -0.48 Increased by +33.33% |
| Aug 12, 24 | -0.47 Decreased by -20.51% | -0.54 Increased by +12.96% |
| May 8, 24 | -0.45 Increased by +11.76% | -0.57 Increased by +21.05% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 25 | 0.00 Decreased by -100.00% | -8.11 M Decreased by -96.38% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 25 | 0.00 Decreased by N/A% | -2.98 M Increased by +3.06% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 25 | 0.00 Decreased by N/A% | -5.23 M Decreased by -30.23% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 25 | 0.00 Decreased by N/A% | -4.53 M Decreased by -19.07% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | 1.47 K Decreased by -23.76% | -4.13 M Decreased by -3.20% | Decreased by -281.02 K% Decreased by -35.36% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -3.07 M Increased by +21.76% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -4.02 M Decreased by -23.73% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | -3.81 M Increased by +10.50% | Decreased by N/A% Decreased by N/A% |